Literature DB >> 13374636

Levarterenol (levophed) therapy in acute myocardial infarction; including case report of recovery following unusually high concentration.

E M HELLER.   

Abstract

Entities:  

Keywords:  ARTERENOL/therapeutic use; MYOCARDIAL INFARCT/therapy

Mesh:

Substances:

Year:  1956        PMID: 13374636      PMCID: PMC1823362     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  6 in total

1.  The treatment of shock associated with myocardial infarction.

Authors:  G C GRIFFITH; W B WALLACE; B COCHRAN; W E NERLICH; W E FRASHER
Journal:  Circulation       Date:  1954-04       Impact factor: 29.690

2.  Arterenol in treatment of shock.

Authors:  A J MILLER; A SHIFRIN; B M KAPLAN; H GOLD; A BILLINGS; L N KATZ
Journal:  J Am Med Assoc       Date:  1953-07-25

3.  The treatment of acute hypotensive states with 1-norepinephrine.

Authors:  W R LIVESAY; D W CHAPMAN
Journal:  Am J Med Sci       Date:  1953-02       Impact factor: 2.378

4.  Tissue necrosis following subcutaneous infiltration with nor-epinephrine; report of two cases.

Authors:  H P GREENWALD; A GOOTNICK; N M LUGER; J A KING
Journal:  N Engl J Med       Date:  1952-02-14       Impact factor: 91.245

5.  Norepinephrine and epinephrine effect on renal hemodynamics, with particular reference to the possibility of vascular shunting and decreasing the active glomeruli.

Authors:  J M MOYER; C A HANDLEY
Journal:  Circulation       Date:  1952-01       Impact factor: 29.690

6.  The clinical use of norepinephrine in the treatment of shock accompanying myocardial infarction and other conditions.

Authors:  G S KURLAND; M MALACH
Journal:  N Engl J Med       Date:  1952-09-11       Impact factor: 91.245

  6 in total
  2 in total

1.  Anti-hypotensive drug induced cardiotoxicity: an in vitro study.

Authors:  Aditi Jain; Vibha Rani
Journal:  In Vitro Cell Dev Biol Anim       Date:  2018-01-10       Impact factor: 2.416

2.  Levarterenol (levophed) therapy in acute myocardial infarction.

Authors:  E M HELLER
Journal:  Can Med Assoc J       Date:  1960-04-30       Impact factor: 8.262

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.